Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet®

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

September 9, 2022

Study Completion Date

November 13, 2022

Conditions
Fed Conditions
Interventions
DRUG

Metformin / Vildagliptin Reference Film Coated Tablets (1000 mg / 50 mg) (Galvumet®)

The subjects randomly received a single oral administration of Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg).

DRUG

Metformin / Vildagliptin Test Film Coated Tablets (1000 mg / 50 mg)

The subjects randomly received a single oral administration of Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg).

Trial Locations (1)

1006

Centre National Chalbi Belkahia de Pharmacovogilance, Tunis

All Listed Sponsors
collaborator

La Société Arabe des Industries Pharmaceutiques-Tunisie

UNKNOWN

collaborator

Centre National Chalbi Belkahia de Pharmacovigilance-Tunisie

UNKNOWN

lead

Reseach Laboratory of Clinical and Experimental Pharmacology

NETWORK